2022
DOI: 10.1038/s41388-022-02193-1
|View full text |Cite
|
Sign up to set email alerts
|

Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…AML is a hazardous, enervating and invasive disease with a poor prognosis (23,24). IDH2 and PHD finger protein 6 mutations exert synergistic effects on leukemia formation through excessive production of 2-HG and damage to DNA repair (25). The mutated IDH2 enzyme exhibits gain-of-function activity and catalyzes the conversion of α-KG to 2-HG, which is involved in the pathogenesis of AML (26,27).…”
Section: Obstructed Hematopoietic Differentiation Caused By Idh2mentioning
confidence: 99%
“…AML is a hazardous, enervating and invasive disease with a poor prognosis (23,24). IDH2 and PHD finger protein 6 mutations exert synergistic effects on leukemia formation through excessive production of 2-HG and damage to DNA repair (25). The mutated IDH2 enzyme exhibits gain-of-function activity and catalyzes the conversion of α-KG to 2-HG, which is involved in the pathogenesis of AML (26,27).…”
Section: Obstructed Hematopoietic Differentiation Caused By Idh2mentioning
confidence: 99%
“…Phf6 knockout HSCs from aged mice show transcriptional profiles similar to young HSCs, and deletion of Phf6 from older mice shows a shift towards a younger HSC transcriptome, suggesting that Phf6 loss may counteract HSC aging (5). Combination of Phf6 loss with overexpression of activating mutants of Notch1 ( 18 ) or Jak3 ( 20 ), or overexpression of wild-type Tlx3 ( 17 ) has been shown to cause T-ALL acceleration, while transgenic crosses of Phf6 deletion with Idh2 mutation produce mixed myeloid-lymphoid leukemias (21). Collectively, the role of PHF6 appears to be the repression of self-renewal, both in normal HSCs as well as in T-ALL (18).…”
Section: Introductionmentioning
confidence: 99%